These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15350573)

  • 21. Atazanavir crystal nephropathy.
    Izzedine H; M'rad MB; Bardier A; Daudon M; Salmon D
    AIDS; 2007 Nov; 21(17):2357-8. PubMed ID: 18090291
    [No Abstract]   [Full Text] [Related]  

  • 22. Atazanavir-containing renal calculi in an HIV-infected patient.
    Anderson PL; Lichtenstein KA; Gerig NE; Kiser JJ; Bushman LR
    AIDS; 2007 May; 21(8):1060-2. PubMed ID: 17457108
    [No Abstract]   [Full Text] [Related]  

  • 23. Efficacy and safety of atazanavir-based highly active antiretroviral therapy in patients with virologic suppression switched from a stable, boosted or unboosted protease inhibitor treatment regimen: the SWAN Study (AI424-097) 48-week results.
    Gatell J; Salmon-Ceron D; Lazzarin A; Van Wijngaerden E; Antunes F; Leen C; Horban A; Wirtz V; Odeshoo L; Van den Dungen M; Gruber C; Ledesma E;
    Clin Infect Dis; 2007 Jun; 44(11):1484-92. PubMed ID: 17479947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urolithiasis in HIV-positive patients treated with atazanavir.
    Couzigou C; Daudon M; Meynard JL; Borsa-Lebas F; Higueret D; Escaut L; Zucman D; Liotier JY; Quencez JL; Asselah K; May T; Neau D; Vittecoq D
    Clin Infect Dis; 2007 Oct; 45(8):e105-8. PubMed ID: 17879904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Case presentation: nephrolithiasis in a patient treated with atazanavir.
    Savini C; James C; Wilson S; Martin H; Szabo S; Scotto V
    J Assoc Nurses AIDS Care; 2008; 19(3):225-7. PubMed ID: 18457764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study).
    Di Giambenedetto S; Fabbiani M; Colafigli M; Ciccarelli N; Farina S; Sidella L; D'Avino A; Mondi A; Cingolani A; Tamburrini E; Murri R; Navarra P; Cauda R; De Luca A
    J Antimicrob Chemother; 2013 Jun; 68(6):1364-72. PubMed ID: 23372058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atazanavir urinary stones in an HIV-infected patient.
    Pacanowski J; Poirier JM; Petit I; Meynard JL; Girard PM
    AIDS; 2006 Oct; 20(16):2131. PubMed ID: 17053366
    [No Abstract]   [Full Text] [Related]  

  • 28. Woman With a Groin Mass.
    Hasslinger CI; Allison CF; Barker JJ; Muns EE; Mackenzie DC
    Ann Emerg Med; 2018 Nov; 72(5):e107-e108. PubMed ID: 30342740
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of an atazanivir associated grade 4 hyperbilirubinaemia with efavirenz.
    Kummer O; Mossdorf E; Battegay M; Elzi L; Bodmer M; Krähenbühl S; Haschke M
    Gut; 2007 Oct; 56(10):1477-8. PubMed ID: 17872579
    [No Abstract]   [Full Text] [Related]  

  • 30. Acquired reactive perforating collagenosis induced by indinavir in 2 patients with HIV disease.
    Calista D; Morri M
    Eur J Dermatol; 2008; 18(1):84-5. PubMed ID: 18086600
    [No Abstract]   [Full Text] [Related]  

  • 31. [Metabolic changes in PI-based HAART. Change to atazanavir: continued effectiveness with improved lipid profile].
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():42-3. PubMed ID: 19024917
    [No Abstract]   [Full Text] [Related]  

  • 32. C-Reactive protein levels over time and cardiovascular risk in HIV-infected individuals suppressed on an indinavir-based regimen: AIDS Clinical Trials Group 5056s.
    Henry K; Kitch D; Dube M; Zackin R; Parker RA; Sprecher D; Hammer S; Currier J;
    AIDS; 2004 Dec; 18(18):2434-7. PubMed ID: 15622323
    [No Abstract]   [Full Text] [Related]  

  • 33. Lipid-lowering efficacy and safety after switching to atazanavir-ritonavir-based highly active antiretroviral therapy in patients with human immunodeficiency virus.
    Nguyen ST; Eaton SA; Bain AM; Rahman AP; Payne KD; Bedimo R; Herrington JD; Maclayton DO; Rodriguez-Barradas MC; Busti AJ
    Pharmacotherapy; 2008 Mar; 28(3):323-30. PubMed ID: 18294112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pseudoaneurysm of the superficial femoral artery associated with osteochondroma--a case report.
    Blazick E; Keeling WB; Armstrong P; Letson D; Back M
    Vasc Endovascular Surg; 2005; 39(4):355-8. PubMed ID: 16079946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. eComment: follow-up for femoral pseudoaneurysms.
    Hudorovic N
    Interact Cardiovasc Thorac Surg; 2009 Mar; 8(3):357-8. PubMed ID: 19223313
    [No Abstract]   [Full Text] [Related]  

  • 36. [False aneurysms of anastomoses after aorto-femoral reconstruction].
    Tiukachëv VE; Butylkin AA; Pruntseva GK; Morozov IV
    Vestn Khir Im I I Grek; 2002; 161(3):48-52. PubMed ID: 12528620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hyperlipidemia in patients with HIV infection treated with protease inhibitors].
    López García F; Mora Rufete A; Escolano Hortelano CM; Gutiérrez Rodero F
    Rev Clin Esp; 1999 Nov; 199(11):780-1. PubMed ID: 10638253
    [No Abstract]   [Full Text] [Related]  

  • 38. Performance of six different ritonavir-boosted protease inhibitor-based regimens in heavily antiretroviral-experienced HIV-infected patients.
    de Mendoza C; Valer L; Ribera E; Barreiro P; Martín-Carbonero L; Ramirez G; Soriano V
    HIV Clin Trials; 2006; 7(4):163-71. PubMed ID: 17065028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment options for post-catheterisation femoral pseudoaneurysm closure.
    Kabłak-Ziembicka A; Przewłocki T; Płazak W; Podolec P; Stopa I; Kozanecki A; Tracz W
    Kardiol Pol; 2005 Mar; 62(3):229-39. PubMed ID: 15830017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement in insulin sensitivity and dyslipidemia in protease inhibitor-treated adult male patients after switch to atazanavir/ritonavir.
    Busti AJ; Bedimo R; Margolis DM; Hardin DS
    J Investig Med; 2008 Feb; 56(2):539-44. PubMed ID: 18317438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.